Global Wholehealth Partners Corp. (GWHP)

[billionsmatter]

Mondays Profile GWHP The Next Major COVID-19 Diagnostics Company

With Extensive Patent Portfolio and $11 Price Target



Dear Fellow Trader,



This $1.50/share medical diagnostics company is set to emerge as a major provider of COVID-19 diagnostics test kits, an estimated $5.1B market.



This company has filed an Emergency Use Application (EUA) with the FDA for its rapid anti-body test with a response pending.



Additionally, this $1.50/share stock recently received analyst coverage, and got a staggering $11.20/share 12-month price target! (Representing an approx. 600%+ upside potential)



In studies performed earlier this year, their covid-19 rapid test produced such an enviable accuracy rate that the Department of the U.S. Navy placed an order for 1000 kits.



Go ahead, see the analyst report >> right here <<

https://www.goldmanresearch.com/202008281284/Opportunity-Research/the-next-major-covid-19-player.html



The test’s accuracy was found to be over 97%, with limited false positives, a major differentiator.



Once approved, the kit has significant advantages over existing tests in use today. These include low cost of $25/test, rapid point-of-care (PoC) results in 15 minutes, which removes the main bottleneck to testing processes, and is made in the USA.



Look here for the full analyst report with $11.20/share price target

Happy Trading!!

Your StockEgg Editor


https://www.goldmanresearch.com/202008281284/Opportunity-Research/the-next-major-covid-19-player.html